UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000026133 |
|---|---|
| Receipt number | R000030029 |
| Scientific Title | The analysis of gut microbiome pre- and post-liver transplantation |
| Date of disclosure of the study information | 2017/02/14 |
| Last modified on | 2017/02/14 17:56:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The analysis of gut microbiome pre- and post-liver transplantation
Acronym
The analysis of gut microbiome pre- and post-liver transplantation
Scientific Title
The analysis of gut microbiome pre- and post-liver transplantation
Scientific Title:Acronym
The analysis of gut microbiome pre- and post-liver transplantation
Region
| Japan |
Condition
Condition
Liver transplantation
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the gut microbiome pre- and post- liver transplantation
Basic objectives2
Others
Basic objectives -Others
To examine the contribution of gut microbiome to clinical course
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To clarify the gut microbiome pre- and post- liver transplantation
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Genders do not matter.
2. Patients who who will visit as outpatient or be admitted to Nagasaki university hospital.
3. Patients who will get colonoscopy in health insurance.
4. Patients providing written informed consent with their own will.
Key exclusion criteria
1. Patients with a high bleeding risk.
2. Patients with some diffuse lesions in clarge olon.
3. Patients with severe general complications
4. Patients who were judged to be inappropriate for this study.
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Satoshi Miuma |
Organization
Nagasaki University Hospital
Division name
Department of Gastroenterology and Hepatology
Zip code
Address
Sakamoto 1-7-1, Nagasaki
TEL
0958197481
miuma1002@gmail.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Satoshi Miuma |
Organization
Nagasaki University Hospital
Division name
Department of Gastroenterology and Hepatology
Zip code
Address
1-7-1 Sakamoto, Nagasaki
TEL
0958197481
Homepage URL
miuma1002@gmail.com
Sponsor or person
Institute
Nagasaki University Hospital
Institute
Department
Personal name
Funding Source
Organization
Nagasaki University Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 02 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2016 | Year | 04 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 07 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Not particular
Management information
Registered date
| 2017 | Year | 02 | Month | 14 | Day |
Last modified on
| 2017 | Year | 02 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030029
